Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Metzler

Showing results (71-80 of 176) with videos related to

Pageof 18
Sort By:
Frontiers in Oncology|January 2, 2023
Corrigendum: Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemiaOliver Schleicher, Annkathrin Horndasch, Manuela Krumbholz, et al.
Blood|December 31, 2002
Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic cloneMarianne Konrad, Markus Metzler, Simon Panzer, et al.
Brain Pathology (Zurich, Switzerland)|April 11, 2014
Insights into the infiltrative behavior of adamantinomatous craniopharyngioma in a new xenotransplant mouse modelChristina Stache, Annett Hölsken, Sven-Martin Schlaffer, et al.
Clinical Pharmacokinetics|May 19, 2026
Therapeutic Drug Monitoring of Imatinib in Paediatric Chronic Myeloid Leukaemia: Towards Practical Implementation and Interpretation of Measured Plasma ConcentrationsPhyllis Lensker, Andrea Gottschalk, Thomas Zerjatke, et al.
BMC Cancer|November 27, 2023
Synergistic lethality in chronic myeloid leukemia - targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatmentLukas Häselbarth, Sara Gamali, Domenica Saul, et al.
The Journal of Investigative Dermatology|July 5, 2016
Genotype, Clinical Course, and Therapeutic Decision Making in 76 Infants with Severe Generalized Junctional Epidermolysis BullosaJohanna Hammersen, Cristina Has, Nora Naumann-Bartsch, et al.
Hemasphere|April 6, 2026
Dynamics of <i>BCR::ABL1</i> transcript levels and clinical outcomes after switch to second-line therapy in pediatric chronic myeloid leukemiaStephanie Sembill, Thomas Zerjatke, Micha Winterstein, et al.
Haematologica|March 18, 2024
Imatinib treatment and longitudinal growth in pediatric patients with chronic myeloid leukemia: influence of demographic, pharmacological, and genetic factors in the German CML-PAED cohortSophie Stiehler, Stephanie Sembill, Oliver Schleicher, et al.
Pediatric Transplantation|May 22, 2021
Course of renal allograft function after diagnosis and treatment of post-transplant lymphoproliferative disorders in pediatric kidney transplant recipientsHenriette Zierhut, Nele Kanzelmeyer, Anja Buescher, et al.
European Journal of Pediatrics|April 28, 2022
Rare pediatric tumors in Germany - not as rare as expected: a study based on data from the Bavarian Cancer Registry and the German Childhood Cancer RegistryAisana Achajew, Ines B Brecht, Martin Radespiel-Tröger, et al.
Pageof 18

Showing results (71-80 of 176) with videos related to

Sort By:
Pageof 18
Frontiers in Oncology|January 2, 2023
Corrigendum: Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemiaOliver Schleicher, Annkathrin Horndasch, Manuela Krumbholz, et al.
Blood|December 31, 2002
Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic cloneMarianne Konrad, Markus Metzler, Simon Panzer, et al.
Brain Pathology (Zurich, Switzerland)|April 11, 2014
Insights into the infiltrative behavior of adamantinomatous craniopharyngioma in a new xenotransplant mouse modelChristina Stache, Annett Hölsken, Sven-Martin Schlaffer, et al.
Clinical Pharmacokinetics|May 19, 2026
Therapeutic Drug Monitoring of Imatinib in Paediatric Chronic Myeloid Leukaemia: Towards Practical Implementation and Interpretation of Measured Plasma ConcentrationsPhyllis Lensker, Andrea Gottschalk, Thomas Zerjatke, et al.
BMC Cancer|November 27, 2023
Synergistic lethality in chronic myeloid leukemia - targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatmentLukas Häselbarth, Sara Gamali, Domenica Saul, et al.
The Journal of Investigative Dermatology|July 5, 2016
Genotype, Clinical Course, and Therapeutic Decision Making in 76 Infants with Severe Generalized Junctional Epidermolysis BullosaJohanna Hammersen, Cristina Has, Nora Naumann-Bartsch, et al.
Hemasphere|April 6, 2026
Dynamics of <i>BCR::ABL1</i> transcript levels and clinical outcomes after switch to second-line therapy in pediatric chronic myeloid leukemiaStephanie Sembill, Thomas Zerjatke, Micha Winterstein, et al.
Haematologica|March 18, 2024
Imatinib treatment and longitudinal growth in pediatric patients with chronic myeloid leukemia: influence of demographic, pharmacological, and genetic factors in the German CML-PAED cohortSophie Stiehler, Stephanie Sembill, Oliver Schleicher, et al.
Pediatric Transplantation|May 22, 2021
Course of renal allograft function after diagnosis and treatment of post-transplant lymphoproliferative disorders in pediatric kidney transplant recipientsHenriette Zierhut, Nele Kanzelmeyer, Anja Buescher, et al.
European Journal of Pediatrics|April 28, 2022
Rare pediatric tumors in Germany - not as rare as expected: a study based on data from the Bavarian Cancer Registry and the German Childhood Cancer RegistryAisana Achajew, Ines B Brecht, Martin Radespiel-Tröger, et al.
Pageof 18